Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants

NCT05759520 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1800

Enrollment

INDUSTRY

Sponsor class

Conditions

Streptococcus Pneumoniae Infection

Interventions

BIOLOGICAL: 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
BIOLOGICAL: Prevenar 13

Sponsor

Fosun Adgenvax Biopharmaceutical Co.,Ltd.